2/23, 5:58 PM (Source: TeleTrader)
more TeleTrader news

AstraZeneca to produce 50M vaccines by April

AstraZeneca Executive Vice President Ruud Dobber shared on Tuesday during a Congress hearing on COVID-19 vaccination that his company could produce up to 50 million doses for the United States by the end of April.

The company official noted that as AstraZeneca is awaiting the approval and emergency use authorization of their vaccine, the manufacturing operations are working at full capacity in the US in order to provide as many shots as possible and to fulfill federal obligations upon confirmation incomings.

"The cost of the doses of the vaccine under those agreements will provide no profit for AstraZeneca. In addition to our vaccine efforts, we have also collaborated with the government and academia on the development of monoclonal antibodies for the prevention and treatment of COVID-19," Dobber said in his opening statement.

Breaking the News / LH